UBE2I and acute myeloid leukemia: Moreover, the current inter-platform study shows the involvement of such less associated with AML TFs as NF-ATs, SMAD3, WT1, and c-Krox, as well as ubiquitous molecules (p300, P/CAF, UBC9), which are involved in posttranslational modifications (acetylation, sumoylation, ubiqutunilation etc.).